USP and Public Policy
Left
Refine Your Search
USP supported S. 4090, the “Dietary Supplement Listing Act of 2022.”
Learn More
The United States Pharmacopeia (USP) has been an independent standards-setting organization serving public health needs since it was founded in 1820. Over the two centuries that followed, USP evolved…
Learn More
USP White Paper on addressing Barriers to the Development of Complex Generics.
Learn More
The U.S. Pharmacopeia (USP) recognizes that global coordination, harmonization, and convergence efforts among governments and other stakeholders can facilitate and streamline responses and solutions…
Learn More
Promoting geographic diversification of the manufacturing base for U.S. drug products can help reduce supply chain vulnerabilities. Published December 2023.
Learn More
Recently, media reports have highlighted the results of drug quality testing from some contract laboratories that are analyzing the quality attributes of human drug products using testing methods…
Learn More
USP supported the Food and Drug Administration's (FDA's) announcement that it will modernize policies to help ensure the availability of safe, well-manufactured, and appropriately labeled…
Learn More
USP supported FDA regarding the value of public standards as they relate to the integrity of dietary supplements.
Learn More
Significant global health gains have been made in the last few decades, in part thanks to increased access to prevention, therapeutics, and services provided by government donors and global financing…
Learn More
Harnessing information to inform effective action to reduce vulnerabilities and prevent or mitigate disruptions in the global supply of quality medicines.
Learn More